ARA290

ARA290

ARA290

ARA-290 Peptide – High-Purity Research Peptide for Tissue Protection & Inflammation Studies

ARA-290 peptide is a synthetic research peptide derived from erythropoietin (EPO), specifically engineered for advanced laboratory and preclinical research. ARA-290 is widely studied in tissue protection, inflammation modulation, neuropathy models, and cellular stress response research, without activating erythropoietic pathways.

ARA-290 is not a drug, supplement, or therapeutic agent.
ARA-290 peptide is intended strictly for laboratory research use only.

What Is ARA-290?

ARA-290 is a non-erythropoietic EPO-derived peptide designed to selectively activate the innate repair receptor (IRR), also known in research as the EPOR–CD131 receptor complex. Unlike full-length erythropoietin, ARA-290 peptide does not stimulate red blood cell production, making it a unique tool for studying cellular protection and anti-inflammatory signaling in controlled laboratory settings.

Because of this selectivity, ARA-290 research focuses on cytoprotective and anti-inflammatory pathways without hematological side effects observed in native EPO models.

ARA-290 Mechanism of Action (Research Context)

In experimental models, ARA-290 is studied for its ability to activate tissue-protective signaling pathways associated with the innate repair receptor. In laboratory research, ARA-290 peptide has been observed to:

• Modulate inflammatory signaling pathways
• Reduce cellular stress responses in vitro
• Support neuronal and tissue protection models
• Influence cytokine activity under experimental conditions
• Demonstrate neuroprotective behavior in cell-based studies

These properties make ARA-290 peptide a valuable research tool for inflammation and tissue repair investigations.

Key Research Applications of ARA-290 Peptide

ARA-290 is commonly used in in-vitro and preclinical research involving:

• Inflammation pathway studies
• Neuropathy and neuroprotection research
• Cellular stress and oxidative damage models
• Tissue repair and regeneration studies
• Cytokine signaling experiments
• Metabolic and mitochondrial research models
• Pain and nerve response research (non-clinical)

Due to its targeted design, ARA-290 peptide research continues to expand in multiple biomedical research fields.

ARA-290 Peptide Specifications

• Product Name: ARA-290 Peptide
• Category: Research Peptide
• Peptide Type: EPO-derived, non-erythropoietic
• Purity: ≥99% (HPLC-verified)
• Form: Lyophilized powder
• Appearance: White to off-white solid
• Solubility: Sterile water, PBS, or DMSO (research protocols may vary)

High purity supports reliable reproducibility and consistent laboratory results.

Storage & Handling Guidelines

To maintain the stability of ARA-290 peptide:

• Store lyophilized peptide at -20°C or lower
• Reconstitute only under sterile laboratory conditions
• Aliquot after reconstitution to minimize degradation
• Avoid repeated freeze–thaw cycles
• Use appropriate PPE and laboratory safety procedures

Why Researchers Choose ARA-290 Peptide

Researchers select ARA-290 peptide for its:

• Selective activation of tissue-protective pathways
• Non-erythropoietic design compared to native EPO
• Strong relevance to inflammation and neuropathy research
• Compatibility with modern peptide research models
• High purity suitable for advanced experimental workflows

ARA-290 continues to be referenced as a benchmark peptide in tissue protection and inflammation research.

Research Use Disclaimer

ARA-290 peptide is sold for laboratory research use only.
Not for human or animal consumption, diagnostic use, or therapeutic application.

All research must be conducted by qualified professionals in properly equipped facilities and in compliance with all applicable regulations.